In vitro and in vivo evaluation of electrochemotherapy with trans-platinum analogue trans-[PtCl2(3-Hmpy)2]

• Main Authors: Kranjc Simona, Cemazar Maja, Sersa Gregor, Scancar Janez, Grabner Sabina
• Format: Article
• Language: English
• Published: Sciendo 2017-09-01
• Series: Radiology and Oncology
• Subjects: platinum analogue; cisplatin; 3-hmpy; electroporation; electrochemotherapy; mouse sarcoma
• Online Access: https://doi.org/10.1515/raon-2017-0034
• ISSN: 1581-3207

Cisplatin is used in cancer therapy, but its side effects and acquired resistance to cisplatin have led to the synthesis and evaluation of new platinum compounds. Recently, the synthesized platinum compound trans-[PtCl2(3-Hmpy)2] (3-Hmpy = 3-hydroxymethylpyridine) (compound 2) showed a considerable cytotoxic and antitumour effectiveness. To improve compound 2 cytotoxicity in vitro and antitumour effectiveness in vivo, electroporation was used as drug delivery approach to increase membrane permeability (electrochemotherapy).